A common goal of microarray experiments is to detect genes that are differentially expressed under distinct experimental conditions. Several statistical tests have been proposed to determine whether the observed changes in gene expression are significant. The t-test assigns a score to each gene on the basis of changes in its expression relative to its estimated variability, in such a way that genes with a higher score (in absolute values) are more likely to be significant. Most variants of the t-test use the complete set of genes to influence the variance estimate for each single gene. However, no inference is made in terms of the variability itself. Here, we highlight the problem of low observed variances in the t-test, when genes with relatively small changes are declared differentially expressed. Alternatively, the ztest could be used although, unlike the t-test, it can declare differentially expressed genes with high observed variances. To overcome this, we propose to combine the z-test, which focuses on large changes, with a v 2 test to evaluate variability. We call this procedure CLEARtest and we provide a combined p-value that offers a compromise between both aspects. Analysis of three publicly available microarray datasets reveals the greater performance of the CLEAR-test relative to the t-test and alternative methods. Finally, empirical and simulated data analyses demonstrate the greater reproducibility and statistical power of the CLEAR-test and z-test with respect to current alternative methods. In addition, the CLEAR-test improves the z-test by capturing reproducible genes with high variability.
Background
In recent years, functional genomic studies based on microarray gene expression analysis have emerged as a powerful strategy through which to decipher cellular processes, pathways or pathology. The vast number of microarray studies published to date provides an opportunity to develop new systems-level, integrated approaches to the understanding of biological processes. However, one of the limitations of microarray-based studies is the validation of the results, that is the set of genes that are declared differentially expressed between distinct experimental conditions. The success of this validation is influenced not only by the use of standardized protocols [1] [2] [3] but also by the statistical method chosen to determine significance. A variety of methods are currently available and concepts such as statistical sophistication and biological interpretation must be taken into account in order to select one or other [4] [5] [6] .
Once the raw data have been pre-processed and normalized, a statistical method is needed to assess the evidence 1532-0464/$ -see front matter Ó 2007 Elsevier Inc. All rights reserved. doi:10.1016/j.jbi. 2007 . 05 . 005 against the null hypothesis of non-differential expression. The t-test assigns a score to each gene on the basis of changes in its expression relative to its estimated variability, which accounts for the error in the estimation of the change. Thus, genes with a high score (in absolute values) are more likely to be significant. A caveat appears, however, when a high score is assigned to a gene with a small change because the observed variance is low. This problem has been noted and explored before (see e.g. [7] [8] [9] ) and it particularly emerges in microarray data analysis as thousands of genes are considered and more possibilities therefore arise for the estimated variance to be small by chance [7] . To overcome this, distinct modifications of the t-test have been developed, which mainly offer more stable variance estimates using the complete set of genes to influence the variance estimate of each single gene (reviewed in [7, 10] ). As an alternative, one could apply a z-test, which uses a single estimated variance that is pooled across all genes [7] . This is effectively a fold change test [7] that imposes a minimum threshold for the observed fold change at a given significance level. A previously noted limitation of the z-test is that it assumes equal variance for all genes, which has two consequences in practice: on the one hand, genes with small fold changes are not declared differentially expressed and, on the other, genes with high variances can be declared differentially expressed. Modified versions of the t-test have been developed in order to find a middle ground [7] , and have been shown to have more power than the conventional t-test in small sample sizes, specifically in detecting genes with large fold changes [9] [10] [11] .
We propose here a novel way for assessing significance in microarray data analysis by Combining differentiaL Expression and vARiability (CLEAR-test). The CLEAR-test solves in parallel two tests, a z-test for differential expression and a v 2 test for variability. This second test is one-sided and evaluates whether the variance is high. With this combined approach, more power is given to detect large changes, and the CLEAR-test will then fail to detect small changes in genes with low variances. Even though the information derived from these genes is probably valuable, genes displaying large changes are usually of primary interest.
Methods

The problem of low variances in the t-test
To illustrate the problem of low variances in the t-test, we first consider the case of two-channel microarray data in which two experimental conditions are co-hybridized. Let x ij be the relative log expression level observed in sample i (i = 1, . . . , n) for gene j (j = 1, . . . , g). Let l j = E[x ij ] be the true log ratio and let r 2 j ¼ V ½x ij be the true variance for gene j. Determining whether a gene is differentially expressed is equivalent to testing the null hypothesis H o : l j = 0 versus the alternative H 1 : l j " 0. Assuming normality of the data ðx ij $ N ðl j ; r 2 j ÞÞ or a large enough sample size (n > 30) (see e.g. [12] ), the t-test is based on the score theoretically consider two possible scenarios, an overestimation or an underestimation of the true variance. Overestimation will cause jt j j to be lower, making the p-value higher, and may lead to a loss of power to reject, while underestimation will cause jt j j to be higher, making the p-value lower, and may lead to a higher probability of obtaining false positives. Particularly, the problem of underestimating variance in the t-test has been explicitly explored by other authors (e.g. [7] [8] [9] ). Fig. 1a shows the limitations of the t-test and z-test through a graphical representation of microarray expression data on the plane defined by the mean and the standard error of the mean. At a given significance level a, the threshold for significance in the t-test is represented by two oblique lines, while in the z-test it is represented by two vertical lines. A gene will be declared significant for the t-test if the ratio between the mean and the standard error of the mean is high enough (in absolute values), and by the z-test if the mean is high enough (in absolute values) independently of the observed variability. For the z-test it is assumed that all genes share the same variance ðx ij $ N ðl j ; r 2 j ¼ r 2 ÞÞ. The problem emerges when genes with large expression changes are declared significant for the z-test but not for the t-test due to high variances, while genes with low changes in expression are excluded from the z-test but are declared significant by the t-test due to a low variance.
A possible solution to this problem is to combine the results of the t-test and the z-test, and declare as differentially expressed those genes identified as significant in both. This analysis would be equivalent to imposing a minimum fold change in the t-test. The CLEAR-test is based on this idea but instead of combining two tests for differential expression, it solves one test for differential expression and another for variability. The aim of the latter test is to detect whether the variance of the gene is higher than the single estimated variance that is pooled across all genes.
The CLEAR-test
Let p 1 , p 2 and p 3 be the following p-values:
The p-values p 1 and p 2 correspond to the t-test and z-test, respectively, and both assess differential expression (H o : l j = 0 versus H 1 : l j " 0). The p-value p 3 corresponds to the classical test of variability, assuming that the data are distributed normally. This test is onesided (H o : r 2 j 6 r 2 versus H 1 : r 2 j > r 2 ) and rejects the null hypothesis when the observed variability is high enough.
In practice, to compute p-values p 2 and p 3 , it is first necessary to know the value of the common variance r 2 . For this purpose, we propose using the mean of the variances
j of all genes in the array. The value of r 2 in the CLEAR-test is a tuneable parameter and, for example, the median of the variances or a value given by the user could be used.
The CLEAR-test then combines inference from p 2 and p 3 (Fig. 1b) . The result is a new gene classification on the plane defined by the mean and the standard error of the mean. At a given significance level a, the thresholds for significance in the CLEAR-test are defined by two vertical lines for differential expression and one horizontal line for variability. Genes significant for p 2 but not for p 3 (red 1 area in Fig. 1b ) are those that are declared differentially expressed (large fold change) and that exhibit a low variability, similar to the variability of non-differentially expressed ones (white area). On the other hand, genes significant for p 2 but also for p 3 (orange area) are those that show differential expression but also higher variability. Finally, genes that are only significant for p 3 (yellow area) are those that do not show differential expression but exhibit higher variability than non-differentially expressed genes (white area).
Differentially expressed genes in the red area of the CLEAR-test might be considered primary candidates for subsequent gene discovery studies. Genes exhibiting high variability in both the orange and yellow areas might indicate the presence of outliers or sample heterogeneity. These genes are candidates for subsequent studies that include class discovery or co-regulation analysis. Although such genes might harbor valuable information for the understanding of biological processes, they are not captured by conventional tests.
To illustrate the four different aspects of the CLEARtest (differential expression, variability, outliers, and sample heterogeneity), we select example genes (A-H) covering the areas defined (Fig. 1c) . Simulated log ratios and the corresponding heatmap provide clues to the significance in a new and not strictly statistical way. Genes D/D 0 are those that will be declared significant in the t-test mainly because of their low variability, but that are rejected in the CLEAR-test because of their small change in expression. Instead, the CLEAR-test declares genes G/G 0 significant on the basis of their high change in expression, even though their high variability might suggest the presence of heterogeneity. Finally, genes E/E 0 , Fig. 1 . Illustration of the t-test, z-test, and CLEAR-test for two-channel microarray data, and for a given n, a and r 2 . Critical areas of the t-test and z-test (a), and of the CLEAR-test (b) are shown. The horizontal axis represents the observed change in the differential expression (mean of log ratios), while the vertical axis represents the estimated variability of this change (standard error of the mean). Formulations of critical points x * , y * , and y 0 are provided in Supplementary Material. (c) Log ratios and heatmaps of hypothetical representative genes (A-H).
F and H, might also indicate the presence of outliers or sample heterogeneity.
Quantification of the problem
We quantify the problem of low variances in the t-test by focusing on the probability of a non-differentially expressed gene (i.e. a gene with null mean and variance r 2 ) being declared significant by the t-test but not for the z-test. Let p be this probability, which can be denoted as follows:
This probability represents the set of genes that are declared significant by the t-test because their variance is underestimated. This probability is independent of r 2 (not shown) and decreases as the number of arrays (n) increases or as the significance level declines. The quantity p a represents the proportion of these genes in the set of ttest significant ones and accounts for the magnitude of the problem. To illustrate this, we simulate data from 10,000 non-differentially expressed, normally distributed genes, and for a particular set of parameters (n = 10; r 2 = 1), and apply the t-test, z-test, and CLEAR-test at a = 0.01 (Fig. 2a) . In this simulation, the proportion of genes in the set of t-test significant ones with their variance being underestimated is 64% 58 58 þ 32
. We obtain the exact quantity p a for a wide range of values of n and a (Fig. 2b ), using simulations (described in Supplementary Material). The results show that analysis of a relatively high number of arrays would not solve the problem and, particularly, if the significance level is low. We explore this problem in practice by using data compiled in the Oncomine database [13] (Supplementary Material, is high, ranging from 20 to 80%, depending on the selected level of significance. Previous studies have systematically evaluated the sample size issue and its effects on microarray data analysis (see e.g. [14] , which uses a z-test approach).
Extension of the analysis to two independent sample sets
We present here the case of two independent sample sets that are separately hybridized on a microarray platform. Let x ijk be the observed log expression level for condition k (k = 1, 2), sample i (i = 1, . . . , n k ), and gene j (j = 1, . . . , g). Let l jk = E [x ijk ] be the true log expression level and r 2 jk ¼ V ½x ijk the true variance for gene j and condition k. As for the analysis of cDNA microarray data, p-values are computed as follows:
where
x ij2 are the sample means for each condition, and S 2 j p is the pooled sample variance across both conditions. This pooled sample variance is computed as S
ple variances of each condition. p-values p 1 and p 2 correspond to the t-test and z-test, respectively, and assess differential expression (H o : l j1 À l j2 = 0). The p-value p 3 assesses variability ðH o : r 2 j 6 r 2 Þ. Computation of p-values assumes normality and equal variance across conditions ðx ijk $ N ðl jk ; r 2 j ÞÞ. As an alternative to assuming variance homogeneity, the approximation described by Welch [21] could be applied. However, under the null hypothesis, this assumption should not represent a problem in practice. Computation of the p-values p 2 and p 3 additionally assumes that non-differentially expressed genes share a common variance (x ijk $ N(l jk , r 2 )) with a value that can be estimated by pooling the variances of all of the genes ðr
Þ.
Extension of the analysis to more than two independent sample sets
Let x ijk be the observed log expression level or relative expression level for condition k (k = 1, . . . , p), sample i (i = 1, . . . , n k ), and gene j (j = 1, . . . , g). Let l jk = E [x ijk ] be the true log expression level or relative expression level, and r 2 jk ¼ V ½x ijk the true variance for gene j and condition k. In this case, the F-test represents the generalization of the t-test and is based on variance decomposition. For each gene, the sum of squares (SSq j ) is decomposed by the sum of squares between (SSq between j ) plus the sum of squares within (SSq within j ), as follows:
x ijk is the sample mean of each condition and
Thus, the F-test computes the score between the mean sum of squares between conditions MeanSSq between j ¼ À
Þ and the mean sum of squares within conditions
Þ. The first one accounts for the variability of the means between conditions and represents the observed change in differential expression, while the second one accounts for variability within conditions and helps to evaluate whether the observed change is significant. The F-test assumes, under the null hypothesis of non-differential expression, that this score follows an F distribution with p À 1 and n À p degrees of freedom. Computation of p 1 is then as follows:
The analogous computations for p 2 and p 3 assume, in addition to normality of data, that all genes share a common variance. Under the null hypothesis of non-differential expression, the sample mean of each condition is then distributed as x jk $ N ð x j ; r 2 n k Þ. Computation of p 2 and p 3 is then as follows:
The p-values p 1 and p 2 correspond to the F-test and its modified version, assuming known variance, and assess differential expression (H o : l j1 = . . . = l jp ). The p-value p 3 assesses variability ðH o : r 2 j 6 r 2 Þ. The CLEAR-test, then, combines inference from p 2 and p 3 . To compute p 2 and p 3 , we propose pooling the variances of all genes to estimate the common variance
MeanSSq within j Þ. In the multi-class scenario presented here, the z-test is therefore extended to a v 2 test. Consequently, this leads to a combination of two v 2 tests that assess both aspects in the CLEAR-test.
Combination of p-values and evaluation of the CLEARtest
As described above, the CLEAR-test computes two different p-values, one for differential expression and another for variability. To provide a single gene ranking using the CLEAR-test, both p-values are combined using a method described by Good [24] , which defines a weighted combination of different p-values into a single value. To adapt this method for the CLEAR-test, we define a new parameter, k (0 < k 6 1 and k " 0.5), which represents the weight given to the p-value of the z-test (p 2 ) and so 1 À k then represents the weight given to the p-value of the variability test (p 3 ). Following Good's approach, we define the statistic Q = p 2 k p 3 1Àk and then we compute the combined p-value as follows:
The final output is therefore a single p-value that combines both aspects of the CLEAR-test.
The k parameter has a relevant impact on the combined p-value, as it determines the weight given to both aspects of the CLEAR-test. The effect of k on the combined p-value is described in Supplementary Material ( Figure S7 ). A value of k lower than 0.5 does not seem valid in practice, unless attention is focused on detecting genes with high variability. For the empirical datasets analysed, we have found that k = 0.8 is a reasonable value that gives the combined CLEAR-test a higher level of reproducibility than current alternative methods (see below). We have also explored an alternative version of the CLEAR-test that combines p-values p 2 and 1 À p 3 . Thus, the second p-value evaluates the null hypothesis H o : r 2 j P r 2 versus H 1 : r 2 j < r 2 and rejects the null hypothesis when the observed variability is low. We have found that this version produces lower reproducibility because it can declare significant genes with low fold change and low variability, in a similar way as the t-test.
The main objective of the combined p-value is to provide a single gene ranking. However, since the resulting gene order searches for a compromise between fold change and variability, some ambiguity can appear (e.g. genes with a extremely high observed variance could be placed in the top positions even if the fold change is low). Nevertheless, the combined p-value serves to compare and validate the CLEAR-test with respect to the alternative methods. In doing so, we carry out external and internal validations based on the reproducibility of the selected genes for each method and we determine the statistical power using simulated data.
Experiments and validations
Analysis of cDNA microarray data
We analyse the Bittner et al. [15] cDNA microarray dataset to illustrate the limitation of the t-test and the performance of the CLEAR-test. This dataset is derived from a study of melanoma tumors in which co-hybridizations were performed using a common reference sample that was a pool of RNA from a non-tumorigenic revertant of a melanoma cell line. To minimize bias, we use an independently pre-processed and publicly available version of the original dataset, which contains 31 samples and log ratios for 3613 genes (Supplementary Material). With a significance level of 0:05 3613 (Bonferroni corrected), the number of genes declared significant for the t-test is 709 (Fig. 3a) . From those genes, 180 (25%) are excluded for the CLEAR-test because their variance is low. The distribution of genes on the plane differs from that shown previously for random data. Even after applying Bonferroni, we observe the presence of a high number of differentially expressed genes (569) and genes showing a high variability (264). These observations suggest the presence of true positives, for differential expression but also for variability. Sample genes are selected to show the different types of behavior stated previously (Fig. 3b) .
Comparison with variants of the t-test
Several alternatives to the conventional t-test have been proposed (reviewed in [7, 10] ), most of which focus on estimation of variance to modify the denominator of the t-test score. Some of these methods add a constant quantity for all genes to the denominator, such as, for example, the fudge factor in the Significance Analysis of Microarrays (SAM) [16] . Other methods use Bayesian estimations, so that the final result is a posteriori estimated variance that is incorporated in the denominator, such as for example in the Random Variance Model (RVM) [11] . In all cases, the complete set of genes influences the variance estimation of each single gene. Consequently, genes with low variability become more unlikely to be significant because of a higher denominator. Once the score is calculated, p-values are computed using parametric or non-parametric methods.
We have restricted ourselves to an empirical comparison using six different methods for the analysis of the Bittner et al. [15] dataset. The methods compared are Empirical Bayes [17, 18] , Moderated t-test (or B-statistic, implemented in LIMMA R package) [8, 19] , RVM [11] , Regularized ttest (or Cyber-t) [9] , SAM [16] and Wilcoxon test. To ensure comparability, we selected the 709 most significant genes for each method that correspond to the same number of significant ones for the Bonferroni-corrected t-test. The results show that the distribution of the 709 genes on the plane is similar for all methods (Fig. 3c) . The number of genes that emerge as significant or that are excluded is relatively low in all cases, with a maximum of 7% (51/709) of differences for SAM. Notably, all methods appear to slightly modify the slope and intercept of the threshold line in the t-test. A more detailed comparison between methods showing that the specific parameters can be modulated to obtain relatively higher modifications is presented in the Supplementary Material. All methods except the Wilcoxon test exclude genes with low observed variances from being significant, while rescue genes that are not significant in the t-test due to high observed variances. The Wilcoxon test only considers the rank of the data, while the observed variance is not taken into consideration. As has been shown, this robustness results in a loss of statistical power [20] .
Analysis of two independent sample sets
To illustrate the CLEAR-test in this case, we use the Golub et al. [22] published dataset, which consists of 27 acute lymphoblastic leukaemia and 11 myeloid leukaemia samples hybridized on an Affymetrix platform. For the analysis, we use a pre-processed dataset with normalized data for 3051 genes (Supplementary Material). Genes are represented in the plane analogous to the situation of one sample set. The horizontal axis shows the change in differential expression ð x j1 À x j2 Þ, while the vertical axis accounts for variability ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi ffi
With the same significance level to that used in the original publication (a = 0.0001), the number of genes declared significant for the t-test is 171 (Fig. 4a) . From those genes, 43 (25%) are excluded for the CLEAR-test, which declares 178 genes as differentially expressed and 233 as showing high variability. Selected genes and their expression levels, and heatmaps, are shown (Fig. 4b) . In their study, Golub et al. [22] generated an expression signature that was externally validated using a test dataset made up of independent samples. We used this signature to evaluate the CLEAR-test. We placed signature genes on the plane defined by the difference of the means and the standard error of this difference (Fig. 4c) . The result shows that most genes in the signature (45 out of 50, 90%) are in the significance areas for differential expression in the CLEAR-test, therefore showing large fold changes. This observation suggests that genes excluded by the CLEARtest compared to the t-test are less likely to be biological meaningful.
The existence of training and test sample sets in Golub et al. [22] allows us to asses the class predictive accuracy of genes selected by the CLEAR-test. Using k = 0.8, 56 probes were found differentially expressed (false discovery rate adjusted p-values $0) in the training set, with six genes being in common with the 50 gene signature originally described [22] . Using the weighted votes method, the CLEAR-test set shows an accuracy of 96% and a median prediction strength (PS) of 0.48 (Supplementary Material). These values are lower than originally reported, being of 100% and 0.73, respectively [22] . The reason why the CLEAR-test approach shows lower PS is because the gene-set is selected by combining fold change and variability but class prediction is performed by applying a method that mainly relies on the expression patterns. Thus, in order to apply the CLEAR-test approach for class prediction it should be combined with a methodology that would include a variability criteria.
Analysis of more than two independent sample sets
To illustrate the CLEAR-test in this case, we use the Hedenfalk et al. [23] published dataset, which consists of seven BRCA1, eight BRCA2, and seven sporadic breast tumors all hybridized against a reference RNA derived from a mammary epithelial cell line on a cDNA microarray platform. For our analysis, we use a pre-processed version of the original dataset that contains log ratios for 3226 genes (Supplementary Material). Genes are represented in a plane where the horizontal axis represents the mean sum of squares between and the vertical axis the mean sum of squares within (Fig. 5a ). With the same significance level as used in the original publication (a = 0.001), the number of genes declared significant for the F-test is 48. From those genes, 29 (60%) are excluded for the CLEAR-test, which declares 78 genes as differentially expressed and 199 as showing high variability. Selected genes and their log relative expression levels are shown (Fig. 5b) .
Hedenfalk et al. [23] declared a set of 54 genes as significant by using a modified F-test. We placed these genes on the plane defined by the mean sum of squares between and the mean sum of squares within (Fig. 5c) . The result shows that a low proportion of those genes (20 out of 54, 37%) are significant for the CLEAR-test. This observation suggests that the problem of low variances is not solved by conven- tional tests or modifications. To visualize this, we present the heatmap of the complete set of genes ordered by their observed change in differential expression (Fig. 5d) . Genes at the bottom exhibit smaller changes between conditions, a finding that suggests lower biological interest. Moreover, F-test p-values do not correlate with the observed change in differential expression.
External and internal validation
We use the test dataset of Golub et al. [22] to externally validate the CLEAR-test. This dataset consists of 20 acute lymphoblastic leukaemia and 14 myeloid leukaemia samples hybridized on the same Affymetrix platform as the train dataset used above. Firstly, we compare the train and test datasets and determine the reproducibility of the genes on the plane used by the CLEAR-test. For this purpose, we define a grid of 100 · 100 equally spaced points on the plane, determine the 50 nearest genes to each point and then compute the overlap between both datasets (Fig. 6a) . The Mahalanobis distance is used to give the same weight to both the horizontal and vertical axes. This is equivalent to scaling both axes by their standard deviation, calculated across all genes, and then computing the natural Euclidean distance. The results of this analysis show that genes with large fold changes are the most reproducible and that those with high variability show an intermediate level of reproducibility. Genes with low fold changes barely overlap even if their variability is low. These observations support the approach developed here that focuses on large fold changes and excludes genes with low variability.
Secondly, we assess the reproducibility of the CLEARtest in comparison to alternative methods using the order in which genes are ranked according to significance. In doing so, we determine the overlap between the train and test datasets across the complete gene ranking. We compute this overlap by comparing the sets of genes in the top 1%, top 2% and successively, according to the order ESTs  ODC  VLDLR  RBL2  KIAA0246  STHAR  ST13  MTMR4  NIFU  HECH  TP53BP2  GNAI3  GPX4  DKFZP564M2423  TFAP2C  CTPS  UGTREL1  SPS  GDI2  PCNA  CAD  PHYH  ITGB8  MCM7  CDK4  BRF1  ILF2  PPP1CB  ESTs  ESTs  HSPC195  ESTs  MX2  CSDA  PFKP  NSEP1  D123  FOXM1  LRP1  ARVCF  ZNF161  TOB1  COX6C  PFKP  TDGFB given by each method (Fig. 6b) . The results indicate that the combined CLEAR-test has the highest level of reproducibility when compared to alternative methods. The conventional t-test shows the lowest level of reproducibility, while the z-test appears in an intermediate position. The CLEAR-test has a higher level of reproducibility than alternative methods because it mainly captures genes with large fold changes, which are truly differentially expressed. In addition, it has higher reproducibility that the z-test because it also captures genes with high variability that are reproducible between both datasets. To further evaluate the CLEAR-test, we perform an internal validation to each dataset. Thus, 100 random partitions of the sample sets into two independent subdatasets are generated. We then compute the mean overlap across all partitions (Supplementary Material, Figure S8 ). The results support the previous observation indicating that the CLEAR-test is more reproducible than the alternative methods.
Simulation results
To provide further evidence that the CLEAR-test performs better than existing tests, we carry out a simulation study. Using the strategy described by Wright and Simon [11] , we generate 2000 simulated datasets from two-channel microarray sets of sizes 10 and 20, and containing 6000 genes. Log ratios for each gene are generated from a normal distribution with mean 0 and variance obtained from an inverse gamma distribution (parameters of shape and scale a = 3 and b = 1, respectively). To 2000 of the 6000 genes, we then add a quantity between 0.2 and 2 (at every 0.2 U) to their log ratios. This set represents the truly differentially expressed genes.
Next, for every gene in each dataset we apply the combined CLEAR-test (at k = 0.8) and the alternative methods. The power of each method is then determined as the percentage of truly differentially expressed genes that are declared significant across simulated data (Fig. 7) . Results show that the combined CLEAR-test has the highest power to detect large fold changes. Differences between the CLEAR-test and alternative methods are greater for lower cutoffs and sample sizes. The power of the z-test is similar to the power of the CLEAR-test, and the conventional ttest is the one with the lowest power.
To investigate the power of the CLEAR-test in an scenario with sample heterogeneity, we simulate data including a set of 1000 genes with differential expression in only half of the samples. Thus, the added quantity to log ratios involves only half of the samples, which results in higher observed variability. Each dataset then contains 4000 non-differentially expressed genes, 2000 differentially expressed genes and 1000 genes differentially expressed in half of the samples. The power is then computed as the percentage of genes from the third set that are declared significant (Supplementary Material, Figure S9) . Results indicate that the combined CLEAR-test and the z-test have greater power than alternatives methods. In addition, the CLEAR-test has an increased power than the z-test in detecting genes with high variability. Study of the false positive/negative tradeoff using the area under the Receiver Operating Curve (ROC) also shows the greater performance of the CLEAR-test and z-test (Supplementary Material, Figure S10 ).
Implementation
We have implemented the CLEAR-test as a set of functions in the R statistical environment that can be downloaded from http://bioinfo.iconcologia.net. We have also implemented the CLEAR-test in the GEPAS integrated environment as a part of the gene selection module [25, 26] . GEPAS allows the use of this test within a complete pipeline of gene expression data analysis, providing facilities for the previous normalization step [27] and for the posterior step of functional annotation of the selected genes [28, 29] . Moreover, it offers the possibility of using the list of genes arranged by their degree of differential expression according to the statistics for studying differential expression of blocks of functionally related genes. By using the FatisScan tool [30] , KEGG pathways or Gene Ontology terms can be analysed as blocks, to find whether they are differentially expressed, even though individual genes are not.
Discussion
Genes with large expression changes are usually of primary interest. However, the t-test can declare a gene significant even if the observed change in differential expression is low, strictly because its observed variance is low. The problem emerges in the t-test because of multiple testing in microarray data analysis, as it creates more possibilities for the variance to be low by chance [7] . Most variants of the t-test are centered on modifying the estimation of the variance, using the complete set of genes to influence the variance estimate for each single gene. These modifications are a move towards solving the problem, but they might not be enough in practice. Probability computations allow us to show that a small number of arrays or a reduced significance level increase the magnitude of the problem (Fig. 2b) , making it particularly relevant for most microarray-based studies (Supplementary Material, Figure S2) .
The CLEAR-test is not strictly a test for differential expression as it incorporates inference for variability. In fact, it combines two classical tests, a z-test and a v 2 test. On the one hand, it evaluates whether genes show large fold changes, while on the other, it assesses when their variability is high. Genes with high variability could suggest the presence of outliers or heterogeneity in the samples. We therefore propose a new visualization of the data for each gene on a plane defined by the observed change against the observed variability. This representation is useful to show the performance of the CLEAR-test and gives additional clues for subsequent biological interpretation.
In addition, statistical power analysis shows the comparative usefulness of the CLEAR-test. Our results indicate that truly differentially expressed genes are principally those that show large observed fold changes, even if they observed variability is high. External and internal reproducibility analyses support this finding. These observations further sustain the z-test approach, which is effectively a fold change test. Then, the CLEAR-test improves the z-test by combining it with a variability test, which allows to capture, in addition, reproducible genes with high variability.
Overall, these analyses demonstrate the greater performance of the z-test, and therefore the CLEAR-test, relative to alternative methods. This apparently surprising result is probably due to the fact that genes with large fold changes are highly reproducible even if their variability is high, while genes with low fold changes and low variability are less reproducible. These findings could open a new direction in microarray data analysis although they may not apply to all types of datasets, depending on the pre-processing and normalization methods applied.
The CLEAR-test concept could be extended to a more general framework of methods where an estimated variability is used to assess whether or not gene expression is related to an outcome of interest. For example, linear models or Cox models for survival analysis could be modified using the CLEAR-test concept. Furthermore, since largescale data analysis is not limited to gene expression and also includes functional and proteomic studies in which the variance of each item is estimated, the CLEAR-test concept could also be extended to them. In addition, the combination of the CLEAR-test with machine learning methods could improve the gene selection step, particularly for expression signature studies.
Here, we have limited ourselves to the study of publicly available datasets previously pre-processed and normalized. It is known that these steps of microarray data analysis have a relevant impact on the later statistical methodology and, therefore, they can also influence the performance of the CLEAR-test. Regarding multiple testing corrections, we have presented the CLEAR-test separately from them. A range of methods can be used in parallel for this purpose. For example, ideas based on the false discovery rate (FDR) can be applied to determine significance thresholds [31] . In addition, for the non-combined version of the CLEAR-test, we undertook the analyses using the same significance level for differential expression and for variability but different levels are allowed. For instance, FDR-based corrections could be independently applied to each set of p-values and then distinct cutoffs could be imposed (Supplementary Material). Notably, with normally distributed data, both p-values are independent, as sample mean and sample variance are also independent, which makes it possible to combine the independently obtained results. The variability test in the CLEAR-test is known to be sensitive to deviations from normality and this fact could represent a problem in practice. Therefore, non-parametric versions of the CLEAR-test could be developed by maintaining the same statistics but basing computations of p-values on free distribution approaches, such as permutations used in SAM [16] .
Conclusions
The CLEAR-test represents a new way for assessing significance in microarray data analysis. The result is a combined inference that defines a classification of the genes that is not strictly statistical and evaluates four distinct aspects: differential expression, variability, outliers and sample heterogeneity. Through the analysis of publicly available datasets, we demonstrate the applicability of the CLEAR-test and its performance over the t-test and modifications. A new graphical visualization serves to illustrate the results providing novel clues for biological interpretation. We propose a combined p-value that offers a compromise between the different aspects of the CLEAR-test and provides a single gene ranking. Empirical and simulated data analyses demonstrate the greater reproducibility and statistical power of the CLEAR-test with respect to current alternative methods.
